Does a former smoker have the same risk as someone who never smoked?

01

‘Former smoker’ describes a category, not a biological reset

In a fictional example, two people both tick ‘former smoker’: one stopped last month after many years of smoking, the other stopped twenty years ago after a shorter history. Their shared label does not make their histories interchangeable. Studies can separate these histories by time since stopping and previous exposure, but an overall former-smoker average blends different people.

Definitions also matter. The four-country 2024 mortality analysis and the 2025 Cross-Cohort study classified people reporting fewer than 100 lifetime cigarettes as ‘never smokers’. This research category is not literal proof of zero lifetime exposure. ‘Nonsmoker’ can also be used more broadly in everyday language; before interpreting a comparison, check whether the study means never smokers or everyone not currently smoking.

[1][3]

02

Two comparisons can both be true

The 2024 four-country analysis linked adult cohorts in the US, UK, Norway and Canada to death registries. Former smokers had lower overall mortality than current smokers, while the overall former-smoker group still had higher mortality than the never-smoker group. That is not a contradiction: one comparison addresses the benefit relative to ongoing smoking; the other addresses a remaining difference relative to a different history.

A percentage of excess risk avoided is another measure—not the percentage of all deaths prevented. It starts with the extra risk above the reference group and compares how much of that extra risk remains. Even a large reduction does not make ordinary background risks disappear. CDC's cessation timelines likewise specify that their decreases in risk refer to stopping compared with continued smoking.

[1][2][4]

03

A heart-death result cannot stand in for every disease

The US study published in the 2024 JAMA Internal Medicine issue examined cardiovascular, cancer and respiratory deaths separately. It excluded very recent quitters and people reporting those diseases at recruitment. Some longer-quit groups had cardiovascular mortality close to never smokers, while excess cancer and respiratory mortality remained even in the group that had stopped at least thirty years earlier. This is evidence about selected groups and causes of death, not a thirty-year deadline for every person's recovery.

The 2025 Cross-Cohort analysis examined heart and vascular events as well as mortality, mainly in US cohorts, with one Brazilian cohort. Some former-smoker comparisons still showed higher risks after 21–30 years. Its event estimates could include recurrent events because all prior cardiovascular conditions could not consistently be excluded. A disease event and death from that disease are different outcomes. Finding no statistically clear difference is also not proof that two groups are exactly equivalent.

[2][3]

04

Use the evidence to keep perspective, not calculate your fate

These are observational comparisons. Illness can prompt stopping, other characteristics differ between groups, and people may stop or restart after the baseline survey. Statistical adjustment and sensitivity analyses address some problems, not all of them. Neither a group's relative risk nor an average gain in survival predicts what will happen to one reader. Remaining risk is a reason for appropriate ongoing care, not evidence that quitting was pointless.

For a personal question about symptoms, prevention or screening, speak with a qualified local healthcare professional; a smoking-status label alone does not determine which care you need. In England, NHS Stop Smoking Services offer an official route for cessation support. This page does not collect your smoking history or calculate a personal risk, and it does not promise that support will erase past exposure.

[1][2][3][4][5]

05

What to keep in mind

• A remaining difference from never smokers does not cancel the benefit compared with continuing.
• Former-smoker averages combine different histories.
• Check the reference group and outcome before accepting a recovery date.